ARCHIVES

DCT Board Ok’s $10.6 Mil. Renewal Of CTEP Contract

This article is from The Cancer Letter archive.

Vol. 16 No. 42 | November 2, 1990

Download PDF Visit The Full Archive

Related Articles

FDA Sets High Bar for Prevention Agents as ODAC Votes Down Proscar And Avodart

December 3, 2010

Nader Group Backs FDA In controversy Over Drug Testing

February 11, 1977

Carbone Names NCI Clinical Director, Rauscher shuffles Treatment Activities

August 30, 1974

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991